Skip to content

Observational study to evaluate the safety and performance of an anti-bacterial wound dressing

Prospective, international, multicenter, observational study to evaluate the clinical performance and safety of a DACC-impregnated transparent postoperative dressing

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/034509
Enrollment
110
Registered
2021-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: NIL: NIL

Sponsors

Essity India Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Signed informed consent to participate in this study 2. Men, women or diverse 3. = 18 years of age 4. Patient is mentally and physically able to participate in this study 5. Wound from gastrointestinal or orthopaedical surgeries indicated for treatment with the investigational products for a time period of 14 days

Exclusion criteria

Exclusion criteria: 1. Infection of the target wound 2. Patients actively taking antibiotics for other conditions up to the day of surgery (not including surgical prophylaxis or antibiotic use related to the index procedure) 3. Subjects require placement of external fixators 4. Any drug addiction including alcohol 5. Known sensitivity or allergy to any component of the study product 6. Patients who participate in any other clinical study investigating drugs or medical devices 7. Patients not willing to attend at follow-up visits 8. Patients not able to give consent 9. Pregnant or breastfeeding patients

Design outcomes

Primary

MeasureTime frame
Primary objective: ? Incidence of superficial and deep surgical site infections after 5 to 7 days Secondary objectives: ? Incidence of superficial and deep surgical site infections after 14 and 30 daysTimepoint: baseline, 7 days post-surgery, 14 days post-surgery and 30 days postsurgery

Secondary

MeasureTime frame
? Incidence of superficial and deep surgical site infections Type of surgical procedure ? Skin damage after dressing removal ? Pain at dressing removal ? Signs of infection ? Wound condition ? Condition of peri-wound skin ? Dressing adhesion ? Patient satisfaction ? Wound care giver satisfactionTimepoint: 7 days post-surgery, 14 days post-surgery and 30 days postsurgery

Countries

India

Contacts

Public ContactHardy Schweigel

Global Clinical Affairs

hardy.schweigel@essity.com004915227752954

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026